STE Company Profile and Key Details

Q: Who are the executives of STE?

Mr. Andrew XilasSenior Vice President & GM of DentalMr. Michael J. TokichSenior Vice President & Chief Financial OfficerMr. Walter M. Rosebrough Jr.Chief Executive Officer Emeritus & Senior AdvisorMr. Daniel A. CarestioPres, Chief Executive Officer & DirectorMr. John Adam ZangerleSenior Vice President, Gen. Counsel & Sec.Julie WinterVice President of Investor Relations & Corporation CommunicationsMs. Karen L. BurtonChief Accounting Officer, Vice President & ControllerMr. Cary L. MajorsSenior Vice President & Pres of HealthcareMs. Mary Clare FraserSVice President & Chief HR OfficerMs. Julia K. MadsenSenior Vice President of Life Sciences

NYSE : STE

STERIS

$243.81

-20.46-7.74%

At Close 4:00 PM

68.34

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

STERIS plc (STE) stock declined over -7.74%, trading at $243.81 on NYSE, down from the previous close of $264.27. The stock opened at $240.19, fluctuating between $226.41 and $251.04 in the recent session.

Stock Snapshot

264.27

Prev. Close

24.01B

Market Cap

226.4101

Day Low

34.05

P/E Ratio

7.16

EPS (TTM)

6.01

Cash Flow per Share

240.19

Open

98.49M

Number of Shares

251.035

Day High

99.6%

Free Float in %

64.93

Book Value

3.87M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	240.19	251.04	226.41	243.81	3.87M
Feb 04, 2026	262.79	266.63	261.85	264.27	852.07K
Feb 03, 2026	262.77	268.74	260.91	261.67	643.12K
Feb 02, 2026	262.13	265.01	261.90	264.24	579.74K
Jan 30, 2026	261.63	263.83	259.33	262.60	1.02M
Jan 29, 2026	261.01	262.84	257.87	261.64	526.69K
Jan 28, 2026	261.35	262.40	259.76	260.86	440.92K
Jan 27, 2026	261.78	265.99	261.78	263.07	491.2K
Jan 26, 2026	260.94	264.41	260.57	263.13	500.27K
Jan 23, 2026	259.61	261.70	255.69	259.52	367.11K
Jan 22, 2026	260.21	263.13	259.02	260.90	335.64K
Jan 21, 2026	259.77	264.08	258.62	261.18	432K
Jan 20, 2026	265.67	267.06	257.88	257.99	496.85K
Jan 16, 2026	267.28	269.44	265.96	268.65	523.53K
Jan 15, 2026	264.27	269.37	261.76	268.26	488.64K
Jan 14, 2026	258.89	264.45	256.51	264.25	460.66K
Jan 13, 2026	260.47	261.02	256.62	259.87	209.55K
Jan 12, 2026	256.50	261.21	255.22	260.77	200.96K
Jan 09, 2026	260.69	262.37	256.58	256.82	380.06K
Jan 08, 2026	257.17	263.08	257.17	260.68	441.1K

Contact Details

Dublin, D02 R296

Ireland

https://www.steris.com 353 123 22000

About Company

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Stock Peers

SYK

1.76+0.49%

Stryker Corporation$362.42 PEN

2.09+0.61%

Penumbra, Inc.$342.01 BIO

-6.36-2.08%

Bio-Rad Laboratories, Inc.$299.54 BIO-B

Bio-Rad Laboratories, Inc.$295.05 GKOS

-1.15-1.00%

Glaukos Corporation$113.52 ABT

0.88+0.81%

Abbott Laboratories$109.08 MDT

1.11+1.09%

Medtronic plc$102.95 ZBH

0.64+0.73%

Zimmer Biomet Holdings, Inc.$88.73 GMED

0.44+0.51%

Globus Medical, Inc.$87.50 ITGR

-0.29-0.34%

Integer Holdings Corporation$85.23

Company Overview

STERIS plc (NYSE:STE) closed at $243.81 USD, losing -$20.46 (-7.74%) from the previous close of $264.27. The stock is currently mid-range between its 52-week high and low $204.90 and $269.44. With a market capitalization of about $24.01 billion, STERIS plc is classified as a large-cap and shows market-like volatility (beta ~1.04). Key stats such as the average daily volume over the past year has been around 592.00 thousand shares, trading with heavier-than-usual volume. Headquartered in Dublin, None, STERIS plc operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Daniel A. Carestio, the company employs approximately 18,000 people and listed since June 01, 1992. STERIS plc provides infection prevention and other procedural products and services worldwide.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -6.66%, SMA50 -5.89%, SMA200 -0.49%). The stock’s 14-day RSI is 33.13 (weak momentum), while the ATR of 7.61 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -9.51% below its high and over 18.99% above its low. Average 10-day trading volume of 990.80 thousand shares is significantly above the 3-month average of 637.45 thousand, indicating heightened recent market interest.

Valuation Metrics

STERIS plc trades at a P/E ratio of 35.02, slightly above the S&P 500 average, with a price-to-sales ratio of 4.23 and a price-to-book ratio of 3.44 trading at moderately above to book value. The P/FCF stands at 25.11, also above market averages.

Dividend & Fair Value

STERIS plc last paid a dividend of 2.4 per share, this equals a trailing yield of roughly 0.87%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $242.98. This means the shares are trading near this model’s fair value.

Earnings & Analyst Outlook

STERIS plc generated EPS of $7.23 over the past year. Five-year average earnings growth is 5.92%. Wall Street analysts project EPS growth of 9.57% annually over the next five years. The latest quarter delivered EPS of $2.47. The next quarter is forecast at $2.88. Next year's EPS is expected at $9.85. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $295.00 to $240.00. The high target offers 21.0% upside. The low target suggests -1.56% downside. The mean target is $271.50. This offers 11.36% upside. STERIS plc earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 05, 2025, missed forecasts by 3.78%. The prior quarter beat by 3.54%. Over the last six quarters, Apple has recorded several small beats. These include 1.0% in August 06, 2024.

Shareholding & Insider Activity

STERIS plc has 98.49 million shares outstanding. The public float is 98.09 million shares, elevated short interest at 1.05% of float. This equals 907.14 thousand shares. The short ratio is 1.35 days. Institutional investors hold 99.0% of the float. Insiders own 0.3%. Rosebrough Walter M Jr holds 51.40 thousand shares, Carestio Daniel A has 51.10 thousand shares and TOKICH MICHAEL J has 42.93 thousand shares. Over the past six months, insider transactions show net selling. They sold 37.50 thousand shares across 8 transactions.

Financial & Profitability Overview

Over the trailing twelve months, STERIS generated $5.46B in revenue, or $55.11 per share. Gross margin was 44.01%, operating margin 15.87%, and net profit margin 11.26%. Returns are modest, with ROA at 6.06% and ROE at 9.31%.
On valuation metrics, STERIS trades at a P/E of 35.02, P/S of 4.23 and P/B of 3.44. The current ratio is 2.37 and quick ratio is 1.63. Operationally, the company’s inventory turnover is 4.82 and cash conversion cycle is 100.80 days. Debt-to-equity is 0.29, supported by a cash flow-to-debt ratio of 0.63.

Quarterly Financial Highlights

For the quarter ended Mar 31, 2025, STERIS posted revenue of $5.46B, down slightly from $5.14B in the prior quarter. Gross profit was $2.40B (margin 44.01%). Operating income was $866.64M (margin 15.9%). Net income was$614.64M (EPS $6.24).
The company ended the quarter with $171.70M in cash and short-term investments, a total debt of $2.20B, and net debt of $2.03B. Total assets were $10.15B, with equity of $6.62B. Financials further reflected stability, with operating cash flow of $1.15B, free cash flow of $778.00M, and capital expenditures of - $370.09M.

Price Forecast & Outlook

Our AI price prediction model suggests that STERIS plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.25%, with price expected at $254.18 by February 19, 2026, within a range of $249.71 to $258.72 3-Month Outlook: Projected fall of -7.74%, reaching $224.94 by May 05, 2026, with a range of $219.01 to $230.69. 1-Year Outlook: Projected gain of 12.32%, with price at $273.85 by February 05, 2027, within a range of $269.38 to $278.26.

Key Takeaways

STERIS plc (NYSE:STE) shares are flat 1.76% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows STERIS plc trading at a premium to the broader market with a P/E of 35.02. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $217.63, suggesting -10.74% downside. Our AI forecast model points to short-term strength (4.25% over two weeks), a medium-term fall (-7.74% over three months), and a longer-term gain (12.32% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current STERIS plc (STE) stock price?

STERIS plc (NYSE: STE) stock price is $243.81 in the last trading session. During the trading session, STE stock reached the peak price of $251.04 while $226.41 was the lowest point it dropped to. The percentage change in STE stock occurred in the recent session was -7.74% while the dollar amount for the price change in STE stock was - $20.46.

STE's industry and sector of operation?

The NYSE listed STE is part of Medical - Devices industry that operates in the broader Healthcare sector. STERIS plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of STE?

Mr. Andrew Xilas
Senior Vice President & GM of Dental
Mr. Michael J. Tokich
Senior Vice President & Chief Financial Officer
Mr. Walter M. Rosebrough Jr.
Chief Executive Officer Emeritus & Senior Advisor
Mr. Daniel A. Carestio
Pres, Chief Executive Officer & Director
Mr. John Adam Zangerle
Senior Vice President, Gen. Counsel & Sec.
Julie Winter
Vice President of Investor Relations & Corporation Communications
Ms. Karen L. Burton
Chief Accounting Officer, Vice President & Controller
Mr. Cary L. Majors
Senior Vice President & Pres of Healthcare
Ms. Mary Clare Fraser
SVice President & Chief HR Officer
Ms. Julia K. Madsen
Senior Vice President of Life Sciences

How STE did perform over past 52-week?

STE's closing price is 18.99% higher than its 52-week low of $204.90 where as its distance from 52-week high of $269.44 is -9.51%.

How many employees does STE have?

Number of STE employees currently stands at 18,000.

Link for STE official website?

Official Website of STE is: https://www.steris.com

How do I contact STE?

STE could be contacted at phone 353 123 22000 and can also be accessed through its website. STE operates from 70 Sir John Rogerson's Quay, Dublin, D02 R296, Ireland.

How many shares of STE are traded daily?

STE stock volume for the day was 3.87M shares. The average number of STE shares traded daily for last 3 months was 592K.

What is the market cap of STE currently?

The market value of STE currently stands at $24.01B with its latest stock price at $243.81 and 98.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	18000
Beta	1.03
Sales or Revenue	$5.46B
5Y Sales Change%	0.549%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Medical - Devices

STE Company Profile and Key Details

STERIS

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook